BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7964748)

  • 21. Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation.
    Iqbal K; Zaidi T; Bancher C; Grundke-Iqbal I
    FEBS Lett; 1994 Jul; 349(1):104-8. PubMed ID: 8045285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected].
    Goedert M; Cohen ES; Jakes R; Cohen P
    FEBS Lett; 1992 Nov; 312(1):95-9. PubMed ID: 1330687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid.
    Dupont-Wallois L; Sautière PE; Cocquerelle C; Bailleul B; Delacourte A; Caillet-Boudin ML
    FEBS Lett; 1995 Jan; 357(2):197-201. PubMed ID: 7805890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dephosphorylation of fetal-tau and paired helical filaments-tau by protein phosphatases 1 and 2A and calcineurin.
    Yamamoto H; Hasegawa M; Ono T; Tashima K; Ihara Y; Miyamoto E
    J Biochem; 1995 Dec; 118(6):1224-31. PubMed ID: 8720139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin).
    Gong CX; Singh TJ; Grundke-Iqbal I; Iqbal K
    J Neurochem; 1994 Feb; 62(2):803-6. PubMed ID: 8294942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.
    Alonso AC; Zaidi T; Grundke-Iqbal I; Iqbal K
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5562-6. PubMed ID: 8202528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The phosphatase inhibitor okadaic acid induces a phosphorylated paired helical filament tau epitope in human LA-N-5 neuroblastoma cells.
    Vandermeeren M; Lübke U; Six J; Cras P
    Neurosci Lett; 1993 Apr; 153(1):57-60. PubMed ID: 7685510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinases involved in the phosphorylation of human tau protein in transfected COS-1 cells.
    Medina M; García-Rocha M; Padilla R; Pérez M; Montejo de Garcini E; Avila J
    Biochim Biophys Acta; 1996 May; 1316(1):43-50. PubMed ID: 8634342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms.
    Liu R; Pei JJ; Wang XC; Zhou XW; Tian Q; Winblad B; Wang JZ
    J Neurochem; 2005 Sep; 94(5):1225-34. PubMed ID: 15992372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments.
    Kenessey A; Yen SH
    Brain Res; 1993 Nov; 629(1):40-6. PubMed ID: 8287279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmortem changes in the phosphorylation state of tau-protein in the rat brain.
    Gärtner U; Janke C; Holzer M; Vanmechelen E; Arendt T
    Neurobiol Aging; 1998; 19(6):535-43. PubMed ID: 10192212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L.
    Bednarski E; Lynch G
    J Neurochem; 1996 Nov; 67(5):1846-55. PubMed ID: 8863489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activity.
    Soulié C; Lépagnol J; Delacourte A; Caillet-Boudin ML
    Neurosci Lett; 1996 Mar; 206(2-3):189-92. PubMed ID: 8710183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
    Grundke-Iqbal I; Iqbal K; Tung YC; Quinlan M; Wisniewski HM; Binder LI
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4913-7. PubMed ID: 3088567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules.
    Shea TB; Fischer I
    FEBS Lett; 1996 Feb; 380(1-2):63-7. PubMed ID: 8603748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phosphorylation of tau protein].
    Uchida T; Ishiguro K
    Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):280-6. PubMed ID: 2120490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP.
    Fleming LM; Johnson GV
    Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):41-7. PubMed ID: 7619080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain.
    Yang SD; Yu JS; Shiah SG; Huang JJ
    J Neurochem; 1994 Oct; 63(4):1416-25. PubMed ID: 7931292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species.
    Boban M; Babić Leko M; Miškić T; Hof PR; Šimić G
    J Neurosci Methods; 2019 May; 319():60-68. PubMed ID: 30278184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition.
    Oikawa N; Kimura N; Yanagisawa K
    Brain Res; 2010 Feb; 1315():137-49. PubMed ID: 20004650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.